NCT04309916View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 22, 2020

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions
Erosive Reflux Disease
Interventions
DRUG

Tegoprazan

Tegoprazan 50mg tablet

DRUG

Esomeprazole

Esomeprazole 40mg tablet

Trial Locations (1)

03722

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY